IPO Parade Marches on with Insys Therapeutics' $55M filing
By Marie Powers
Thursday, March 31, 2011
In yet another sign that the biotech industry seems to be tracking the U.S. economy's slow but steady recovery, Insys Therapeutics Inc., of Phoenix, filed with the SEC on Wednesday to raise up to $55 million in an initial public offering (IPO).
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.